Alzheimer's disease as copper deficiency

Medical Hypotheses

Volumn 70, Issue 4, 2008, Pages 802-807

  Klevay, Leslie M ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; CERULOPLASMIN; COPPER; CYTOCHROME C OXIDASE; OROTATE COPPER; TAU PROTEIN; UNCLASSIFIED DRUG; ZINC;

ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; COGNITION; COPPER DEFICIENCY; DEMENTIA; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE COURSE; DOWN SYNDROME; HUMAN; MYELINATION; NONHUMAN; NUTRITIONAL REQUIREMENT; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SUPPLEMENTATION;

ANIMALIA;

EID: 39849096023     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.04.051     Document Type: Article

References (86)

1. L.M. Klevay Elements of ischemic heart disease Perspect Biol Med 20 1977 186 192
2. L.M. Klevay Four ways of becoming ill Med Hypotheses 27 1988 65 70
3. L.M. Klevay Ischemic heart disease as deficiency disease Cell Mol Biol (Noisy-le-grand) 50 2004 877 884
4. L.M. Klevay How dietary deficiency, genes and a toxin can cooperate to produce arteriosclerosis and ischemic heart disease Cell Mol Biol (Noisy-le-grand) 52 2006 11 15
5. A. Alzheimer Über eine eigenartige Erkrankung der Hirnrinde Allg Z Psychiatr Gerichtl Med 64 1907 146 148
6. S.I. Magalini S.C. Magalini G. de Francisci Dictionary of medical syndromes 3rd ed. 1990 J.B. Lippincott Philadelphia
7. G.W. Small Alzheimer’s disease and other dementias B.J. Sadock V.A. Sadock Kaplan & Sadock’s comprehensive textbook of psychiatry 8th ed. 2005 Lippincott Williams & Wilkins Philadelphia 3687 3693
8. J. Poirier M. Danik J.P. Blass Pathophysiology of the Alzheimer syndrome S. Gauthier Clinical diagnosis and management of Alzheimer’s disease 2nd ed. 1999 Martin Dunitz, Ltd. 17 32
9. A.H. Ropper R.H. Brown Adams and Victor’s principles of neurology 8th ed. 2005 McGraw-Hill New York p. 898–904
10. J.A. Neugroschl A. Kolevzon S.C. Samuels D.B. Marin Dementia B.J. Sadock V.A. Sadock Kaplan & Sadock’s comprehensive textbook of psychiatry 8th ed. 2005 Lippincott Williams & Wilkins Philadelphia 1068 1093
11. M.P. Frosch D.C. Anthony U. De Girolami The central nervous system V. Kumar A.K. Abbas N. Fausto Robbins and Cotran Pathologic basis of disease 7th ed. 2005 Elsevier Philadelphia 1347 1419
12. M. Sjobeck M. Haglund E. Englund Decreasing myelin density reflected increasing white matter pathology in Alzheimer’s disease – a neuropathological study Int J Geriatr Psychiatry 20 2005 919 926
13. C.A. Davies D.M. Mann P.Q. Sumpter P.O. Yates A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer’s disease J Neurol Sci 78 1987 151 164
14. J.E. Hamos L.J. DeGennaro D.A. Drachman Synaptic loss in Alzheimer’s disease and other dementias Neurology 39 1989 355 361
15. S.T. DeKosky S.W. Scheff Synapse loss in frontal cortex biopsies in Alzheimer’s disease: correlation with cognitive severity Ann Neurol 27 1990 457 464
16. S. de Lacalle I. Iraizoz L.M. Gonzalo Cell loss in supraoptic and paraventricular nucleus in Alzheimer’s disease Brain Res 609 1993 154 158
17. S.W. Scheff D.A. Price Synapse loss in the temporal lobe in Alzheimer’s disease Ann Neurol 33 1993 190 199
18. G. Leuba R. Kraftsik Visual cortex in Alzheimer’s disease: occurrence of neuronal death and glial proliferation, and correlation with pathological hallmarks Neurobiol Aging 15 1994 29 43
19. A. Brun X. Liu C. Erikson Synapse loss and gliosis in the molecular layer of the cerebral cortex in Alzheimer’s disease and in frontal lobe degeneration Neurodegeneration 4 1995 171 177
20. C. Bertoni-Freddari P. Fattoretti T. Casoli U. Caselli W. Meier-Ruge Deterioration threshold of synaptic morphology in aging and senile dementia of Alzheimer’s type Anal Quant Cytol Histol 18 1996 209 213
21. S.W. Scheff D.L. Sparks D.A. Price Quantitative assessment of synaptic density in the outer molecular layer of the hippocampal dentate gyrus in Alzheimer’s disease Dementia 7 1996 226 232
22. S.W. Scheff D.A. Price Synaptic density in the inner molecular layer of the hippocampal dentate gyrus in Alzheimer disease J Neuropathol Exp Neurol 57 1998 1146 1153
23. S.W. Scheff D.A. Price F.A. Schmitt E.J. Mufson Hippocampal synaptic loss in early Alzheimer’s disease and mild cognitive impairment Neurobiol Aging 27 2006 1372 1384
24. R.D. Terry E. Masliah D.P. Salmon Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment Ann Neurol 30 1991 572 580
25. K. Blennow N. Bogdanovic I. Alafuzoff R. Ekman P. Davidsson Synaptic pathology in Alzheimer’s disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele J Neural Transm 103 1996 603 618
26. X. Liu C. Erikson A. Brun Cortical synaptic changes and gliosis in normal aging, Alzheimer’s disease and frontal lobe degeneration Dementia 7 1996 128 134
27. P. Davidsson K. Blennow Neurochemical dissection of synaptic pathology in Alzheimer’s disease Int Psychogeriatr 10 1998 11 23
28. W.A. Kaufmann U. Barnas C. Humpel Synaptic loss reflected by secretoneurin-like immunoreactivity in the human hippocampus in Alzheimer’s disease Eur J Neurosci 10 1998 1084 1094
29. C. Bancher K. Jellinger H. Lassmann P. Fischer F. Leblhuber Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia Eur Arch Psychiatry Clin Neurosci 246 1996 137 146
30. X. Liu U. Passant J. Risberg S. Warkentin A. Brun Synapse density related to cerebral blood flow and symptomatology in frontal lobe degeneration and Alzheimer’s disease Dement Geriatr Cogn Disord 10 Suppl 1 1999 64 70
31. S. Singh G.P. Mulley M.S. Losowsky Why are Alzheimer patients thin? Age Ageing 17 1988 21 28
32. W.G. Berlinger J.F. Potter Low Body Mass Index in demented outpatients J Am Geriatr Soc 39 1991 973 978
33. G.P. Wolf-Klein F.A. Silverstone A.P. Levy Nutritional patterns and weight change in Alzheimer patients Int Psychogeriatr 4 1992 103 118
34. E. Barrett-Connor S. Edelstein J. Corey-Bloom W. Wiederholt Weight loss precedes dementia in community-dwelling older adults J Nutr Health Aging 2 1998 113 114
35. H. White C. Pieper K. Schmader The association of weight change in Alzheimer’s disease with severity of disease and mortality: a longitudinal analysis J Am Geriatr Soc 46 1998 1223 1227
36. P.N. Wang C.L. Yang K.N. Lin W.T. Chen L.C. Chwang H.C. Liu Weight loss, nutritional status and physical activity in patients with Alzheimer’s disease. A controlled study J Neurol 251 2004 314 320
37. A.S. Buchman R.S. Wilson J.L. Bienias R.C. Shah D.A. Evans D.A. Bennett Change in body mass index and risk of incident Alzheimer disease Neurology 65 2005 892 897
38. R. Stewart K. Masaki Q.L. Xue A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study Arch Neurol 62 2005 55 60
39. H.K. White E.S. McConnell C.W. Bales M. Kuchibhatla A 6-month observational study of the relationship between weight loss and behavioral symptoms in institutionalized Alzheimer’s disease subjects J Am Med Dir Assoc 5 2004 89 97
40. M.H.N. Golden Severe malnutrition D.J. Weatherall J.G. Ledingham D.A. Warrell Oxford textbook of medicine 3rd ed. 1996 Oxford University Press Oxford 1278 1296
41. M.C. Linder C.A. Goode Biochemistry of Copper 1980 Plenum Press New York p. 89, 200, 211, 228–229, 252–254, 266–273
42. L.M. Klevay J.P. Buchet V.W. Bunker Copper in the western diet (Belgium, Canada, UK and USA) M. Anke D. Meissner C.F. Mills Trace Elements in Man and Animals – TEMA 8 1993 Verlag Media Touristik Gersdorf, Germany 207–210
43. L.M. Klevay Lack of a recommended dietary allowance for copper may be hazardous to your health J Am Coll Nutr 17 1998 322 326
44. Y. Pang D.L. MacIntosh P.B. Ryan A longitudinal investigation of aggregate oral intake of copper J Nutr 131 2001 2171 2176
45. Anon Copper. Dietary reference intakes for vitamin A vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium and zinc 1st ed. 2001 National Academy of Sciences Washington, D.C. p.1 [chapter 7]
46. M.B. Pepys The acute phase response and C-reactive protein D.J. Weatherall J.G. Ledingham D.A. Warrell Oxford textbook of medicine 3rd ed. 1996 Oxford University Press Oxford 1527 1533
47. C.A. Owen Jr Biochemical aspects of copper 1st ed. 1982 Noyes Publications Park Ridge, N.J. p. 22, 34, 86, 133–134
48. C.A. Owen Jr Copper deficiency and toxicity 1st ed. 1981 Noyes Publications Park Ridge, N.J. 6–8, 12, 16, 17
49. V.A. McKusick C.A. Francomano S.E. Antonarakis P.L. Pearson Mendelaian inheritance in man 11th ed. 1994 The Johns Hopkins University Press Baltimore 93, 805, 2268
50. L.M. Klevay Re: Serum copper and the risk of acute myocardial infarction: a prospective population study in men in eastern Finland Am J Epidemiol 135 1992 832 834
51. P.M. May P.W. Linder D.R. Williams Ambivalent effect of protein binding on computed distributions of metal ions complexed by ligands in blood plasma Experientia 32 1976 1492 1494
52. P.M. May P.W. Linder D.R. Williams Computer simulation of metal-ion equilibria in biofluids: Models for the low-molecular-weight complex distribution of calcium(II), magnesium(II), manganese(II), iron(III), copper(II), zinc(II), and lead(II) ions in blood plasma J Chem Soc, Dalton Trans 1977 588 595
53. G.K. Davis W. Mertz Copper W. Mertz Trace elements in human and animal nutrition 1st ed. 1987 Academic Press San Diego
54. N. Kumar Copper deficiency myelopathy (human swayback) Mayo Clin Proc 81 2006 1371 1384
55. E.J. Underwood Trace elements in human and animal nutrition 4th ed. 1977 Academic Press New York p. 61, 226, 231
56. L.M. Klevay Interactions of copper and zinc in cardiovascular disease Ann NY Acad Sci 355 1980 140 151
57. L.M. Klevay The illness and death of a female hyena poisoned by zinc ingested as pennies J Zoo Wildl Med 31 2000 289 290
58. S.K. Narayan N. Kaveer CNS demyelination due to hypocupremia in Wilson’s disease from overzealous treatment Neurol India 54 2006 110 111
59. L.-O. Plantin U. Lying-Tunell K. Kristensson Trace elements in the human central nervous system studied with neutron activation analysis Biol Trace Element Res 13 1987 69 75
60. M.A. Deibel W.D. Ehmann W.R. Markesbery Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer’s disease: possible relation to oxidative stress J Neurol Sci 143 1996 137 142
61. J.R. Connor P. Tucker M. Johnson B. Snyder Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer’s disease Neurosci Lett 159 1993 88 90
62. S.J. Kish C. Bergeron A. Rajput Brain cytochrome oxidase in Alzheimer’s disease J Neurochem 59 1992 776 779
63. N.A. Simonian B.T. Hyman Functional alterations in Alzheimer’s disease: diminution of cytochrome oxidase in the hippocampal formation J Neuropathol Exp Neurol 52 1993 580 585
64. K. Chandrasekaran T. Giordano D.R. Brady J. Stoll L.J. Martin S.I. Rapoport Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease Brain Res Mol Brain Res 24 1994 336 340
65. E.M. Mutisya A.C. Bowling M.F. Beal Cortical cytochrome oxidase activity is reduced in Alzheimer’s disease J Neurochem 63 1994 2179 2184
66. P. Chagnon C. Betard Y. Robitaille A. Cholette D. Gauvreau Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases Neuroreport 6 1995 711 715
67. F. Gonzalez-Lima J. Valla S. Matos-Collazo Quantitative cytochemistry of cytochrome oxidase and cellular morphometry of the human inferior colliculus in control and Alzheimer’s patients Brain Res 752 1997 117 126
68. M. Wong-Riley P. Antuono K.C. Ho Cytochrome oxidase in Alzheimer’s disease: biochemical, histochemical, and immunohistochemical analyses of the visual and other systems Vision Res 37 1997 3593 3608
69. J. Ojaimi C.L. Masters C. McLean K. Opeskin P. McKelvie E. Byrne Irregular distribution of cytochrome c oxidase protein subunits in aging and Alzheimer’s disease Ann Neurol 46 1999 656 660
70. S.M. de la Monte T. Luong T.R. Neely D. Robinson J.R. Wands Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer’s disease Lab Invest 80 2000 1323 1335
71. I. Maurer S. Zierz H.J. Moller A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients Neurobiol Aging 21 2000 455 462
72. R.W. Verwer K.A. Jansen A.A. Sluiter C.W. Pool W. Kamphorst D.F. Swaab Decreased hippocampal metabolic activity in Alzheimer patients is not reflected in the immunoreactivity of cytochrome oxidase subunits Exp Neurol 163 2000 440 451
73. J. Valla J.D. Berndt F. Gonzalez-Lima Energy hypometabolism in posterior cingulate cortex of Alzheimer’s patients: superficial laminar cytochrome oxidase associated with disease duration J Neurosci 21 2001 4923 4930
74. F. Bosetti F. Brizzi S. Barogi Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer’s disease Neurobiol Aging 23 2002 371 376
75. N.S. Hamblet B. Ragland M. Ali B. Conyers F.J. Castora Mutations in mitochondrial-encoded cytochrome c oxidase subunits I, II, and III genes detected in Alzheimer’s disease using single-strand conformation polymorphism Electrophoresis 27 2006 398 408
76. F.G. Pajonk H. Kessler T. Supprian Cognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer’s disease J Alzheimers Dis 8 2005 23 27
77. J. Snaedal J. Kristinsson S. Gunnarsdottir X.Y. Olafsdottir M. Baldvinsson T. Johannesson Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer’s disease a case-control study. Dement Geriatr Cogn Disord 9 1998 239 242
78. H. Kessler F.G. Pajonk P. Meisser Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer’s disease J Neural Transm 113 2006 1763 1769
79. A.L. Phinney B. Drisaldi S.D. Schmidt In vivo reduction of amyloid-beta by a mutant copper transporter Proc Natl Acad Sci USA 100 2003 14193 14198
80. L.M. Klevay Copper deficiency increases serum amyloid A in adult mice FASEB J 16 2002 A374
81. T.A. Bayer S. Schafer A. Simons Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice Proc Natl Acad Sci USA 100 2003 14187 14192
82. E. Gaggelli H. Kozlowski D. Valensin G. Valensin Copper homeostasis and neurodegenerative disorders (Alzheimer’s, prion, and Parkinson’s diseases and amyotrophic lateral sclerosis) Chem Rev 106 2006 1995 2044
83. C. Behl Neuroprotective strategies in Alzheimer’s disease C. Alzheimer Molecular and cellular biology of neuroprotection in the CNS (Adv Exp Med Biol. 513:475–496) 2002 Kluwer New York 475 496
84. R.H. Folllis Jr G.V. Mann Pellagra W.W. Wintrobe G.W. Thorn R.D. Adams I.L. Bennett Jr E. Braunwald K.J. Isselbacher R.G. Petersdorf Harrison’s Principles of internal medicine 6th ed. 1970 Braun New York 403 406
85. H. Kessler F.G. Pajonk T. Supprian P. Falkai G. Multhaup T.A. Bayer Zur Bedeutung von Kupfer fur die Pathophysiologie der Alzheimer-Krankheit Nervenarzt 76 2005 581 585
86. I. Giaever Electron tunneling and superconductivity (Nobel lecture) Science 183 1973 1253 1258